United Capital Management of KS’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.3M | Buy |
|
|||||
|
2025
Q1 | $14.5M | Buy |
|
|||||
|
2024
Q4 | $15.6M | Buy |
|
|||||
|
2024
Q3 | $16.8M | Buy |
|
|||||
|
2024
Q2 | $12.7M | Buy |
|
|||||
|
2024
Q1 | $12.5M | Buy |
|
|||||
|
2023
Q4 | $9.29M | Buy |
|
|||||
|
2023
Q3 | $7.46M | Buy |
|
|||||
|
2023
Q2 | $8.33M | Buy |
|
|||||
|
2023
Q1 | $6.9M | Buy |
|
|||||
|
2022
Q4 | $7.38M | Buy |
|
|||||
|
2022
Q3 | $5.6M | Buy |
|
|||||
|
2022
Q2 | $5.19M | Buy |
|
|||||
|
2022
Q1 | $6.22M | Buy |
|
|||||
|
2021
Q4 | $3.95M | Buy |
|
|||||
|
2021
Q3 | $3.96M | Buy |
|
|||||
|
2021
Q2 | $3.91M | Buy |
|
|||||
|
2021
Q1 | $3.67M | Buy |
|
|||||
|
2020
Q4 | $3.63M | Buy |
|
|||||
|
2020
Q3 | $2.74M | Buy |
|
|||||
|
2020
Q2 | $2.52M | Sell |
|
|||||
|
2020
Q1 | $1.77M | Buy |
|
|||||
|
2019
Q4 | $1.83M | Buy |
|
|||||
|
2019
Q3 | $1.34M | Buy |
|
|||||
|
2019
Q2 | $1.43M | Buy |
|
|||||
|
2019
Q1 | $1.32M | Buy |
|
|||||
|
2018
Q4 | $1.01M | Buy |
|
|||||
|
2018
Q3 | $1.32M | Buy |
|